- Trials with a EudraCT protocol (26)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
26 result(s) found for: Inotrope.
Displaying page 1 of 2.
EudraCT Number: 2016-002427-28 | Sponsor Protocol Number: CIT-003-01 | Start Date*: 2018-10-24 |
Sponsor Name:Asklepion Pharmaceuticals, LLC | ||
Full Title: A Phase III Double-Blind, Randomized, Placebo Controlled, Multi-Center Clinical Study to Evaluate the Efficacy and Safety of Intravenous L-citrulline for the Prevention of Clinical Sequelae of Acut... | ||
Medical condition: Post-operative pulmonary dysfunction induced by cardiopulmonary bypass in pediatric subjects undergoing surgery for congenital heart defects. | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003284-62 | Sponsor Protocol Number: 012508 | Start Date*: 2019-07-18 |
Sponsor Name:Queen Mary University London | ||
Full Title: A randomised, blinded, placebo controlled, Phase 2a study to evaluate the safety and efficacy of administering Regadenoson to patients with critical injury and signs of haemorrhagic shock | ||
Medical condition: Cardiovascular collapse following traumatic haemorrhage | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004171-37 | Sponsor Protocol Number: CH/2005/1944 | Start Date*: 2006-08-02 |
Sponsor Name:United Bristol Healthcare Trust | ||
Full Title: Oxidative Stress in children undergoing cardiopulmonary bypass: A trial of Sildenafil therapy | ||
Medical condition: Congenital Heart Disease | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004398-76 | Sponsor Protocol Number: gjnh/mccormick/01 | Start Date*: 2006-03-22 |
Sponsor Name:Golden Jubilee National Hospital | ||
Full Title: A comparison of Myocardial Protection Using Preconditioning with Sevoflurane Against High Thoracic Epidural Analgesia for CABG Surgery | ||
Medical condition: Ischaemic heart disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001922-24 | Sponsor Protocol Number: 120541 | Start Date*: 2013-07-12 | |||||||||||
Sponsor Name:University College London (UCL) | |||||||||||||
Full Title: The effect of remote ischaemic preconditioning and glyceryl trinitrate on peri-operative myocardial injury in cardiac bypass surgery patients (ERIC-GTN study)- a four arm randomised controlled trial | |||||||||||||
Medical condition: We are investigating the phenomenon of ischaemic-reperfusion injury. Reperfusion of the ischaemic myocardium is known to cause further myocardial damage. We wish to investigate the phenomenon of Re... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-017081-23 | Sponsor Protocol Number: CPRC2009 - OPTIMA CC | Start Date*: 2010-03-22 | |||||||||||
Sponsor Name:Centre Hospitalier Universitaire de Nancy | |||||||||||||
Full Title: Optimisation du traitement du choc cardiogénique. Etude pilote physiopathologique ouverte multicentrique comparant l’efficacité et la tolérance de l’adrénaline et la noradrénaline (Optima CC) | |||||||||||||
Medical condition: choc cardiogénique | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-003733-24 | Sponsor Protocol Number: EPO2008-02 | Start Date*: 2009-05-29 |
Sponsor Name:Abertawe Bro Morgannwg University NHS Trust | ||
Full Title: A randomised study to assess the effects of Epoetin Beta on renal function in patients with critical illness(with or without multi-organ failure) | ||
Medical condition: Sepsis/Acute renal failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2009-016880-13 | Sponsor Protocol Number: ITU version1 19/10/2009 | Start Date*: 2011-03-11 |
Sponsor Name:UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST | ||
Full Title: RANDOMIZED CONTROLLED TRIAL OF THE EFFECTS OF PARENTERAL FISH OIL EMULSION IN CRITICALLY ILL SEPTIC PATIENTS IN THE INTENSIVE CARE UNIT | ||
Medical condition: Sepsis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-001563-74 | Sponsor Protocol Number: PHRCN2018/LEVOHEARTSHOCK-LEVY/YB | Start Date*: 2020-07-24 | |||||||||||
Sponsor Name:CHRU de Nancy | |||||||||||||
Full Title: Effect of early use of levosimendan versus placebo on top of a conventional strategy of inotrope use on a combined morbidity-mortality endpoint in patients with cardiogenic shock. LevoHeartShock St... | |||||||||||||
Medical condition: Cardiogenic shock | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002661-35 | Sponsor Protocol Number: FERRICCABG01 | Start Date*: 2020-04-23 | ||||||||||||||||
Sponsor Name:King's College London [...] | ||||||||||||||||||
Full Title: Effect of Iron Isomaltoside on Perioperative Myocardial Injury in Patients Undergoing Coronary Artery Bypass Graft ± Valve Surgery: The Ferric Iron in Coronary Artery Bypass Grafting (FERRIC-CABG) ... | ||||||||||||||||||
Medical condition: Coronary or heart valve disease needing cardiac surgery | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004526-33 | Sponsor Protocol Number: PDARCT1 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Royal College of Surgeons in Ireland | |||||||||||||
Full Title: A Randomised Controlled Trial of Early Targeted Patent Ductus Arteriosus Treatment Using a Risk Based Severity Score | |||||||||||||
Medical condition: Patent Ductus Arteriosus | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003181-12 | Sponsor Protocol Number: HOTPOT1 | Start Date*: 2016-10-07 |
Sponsor Name:Royal College of Surgeons in Ireland | ||
Full Title: Can sonographic assessment of pulmonary vascular reactivity following maternal hyperoxygenation therapy predict neonatal outcome in fetuses at risk of pulmonary hypertension? | ||
Medical condition: Persistent pulmonary hypertension of the newborn (PPHN) is a relatively common condition occurring in 7/1000 births and can result in significant cardiovascular instability in the newborn. It occur... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: IE (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-006843-29 | Sponsor Protocol Number: CKI-303 | Start Date*: 2007-06-13 | |||||||||||
Sponsor Name:NovaCardia Inc | |||||||||||||
Full Title: A multicentre, randomized, double-blind, placebo controlled study of the effects of KW-3902 Injectable Emulsion on heart failure signs and symptoms, diuresis, renal function, and clinical outcomes ... | |||||||||||||
Medical condition: Patients being admitted to hospital with heart failure and volume overload requiring IV therapy after experiencing worsening of renal function. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) IT (Completed) PL (Completed) GR (Completed) BE (Completed) GB (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-001262-35 | Sponsor Protocol Number: D1690C00078 | Start Date*: 2023-02-09 | |||||||||||
Sponsor Name:The Brigham and Women's Hospital, Inc. | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Trial to Evaluate the Effect of In-Hospital Initiation of Dapagliflozin on Clinical Outcomes in Patients Who Have Been St... | |||||||||||||
Medical condition: The study is evaluating the effect of In-hospital initiation of dapagliflozin in patients who have been stabilized during hospitalization for Acute Heart Failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Ongoing) HU (Ongoing) CZ (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000404-42 | Sponsor Protocol Number: RH-ITA-007 | Start Date*: 2018-03-20 | |||||||||||
Sponsor Name:Dept. of Intensive Care, Copenhagen University Hospital, Rigshospitalet | |||||||||||||
Full Title: The Conservative vs. Liberal Approach to fluid therapy of Septic Shock in Intensive Care Trial | |||||||||||||
Medical condition: Septic shock | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) SE (Completed) CZ (Completed) ES (Prematurely Ended) BE (Ongoing) FI (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000588-26 | Sponsor Protocol Number: ICCE12.001 | Start Date*: 2012-10-16 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Pharmacokinetics of Levosimendan in children with acute heart failure | ||
Medical condition: Acute heart failure in children | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) FI (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003468-19 | Sponsor Protocol Number: NL50040.029.14 | Start Date*: 2015-01-08 | |||||||||||
Sponsor Name:VU University Medical Center | |||||||||||||
Full Title: The effects of hyperoxia on organ dysfunction and outcome in critically ill patients with SIRS | |||||||||||||
Medical condition: Intensive Care patients with the systemic inflammatory response syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-005247-78 | Sponsor Protocol Number: OB003 | Start Date*: 2022-01-19 | |||||||||||
Sponsor Name:Oxygen Biotech s.r.o. | |||||||||||||
Full Title: A 2-Part, Open-label, Non-randomized (Part A) and Randomized, Double-blinded, Placebo-controlled (Part B) multicentric, international study with adaptive design to evaluate safety and tolerability ... | |||||||||||||
Medical condition: COVID-19 patients suffering from moderate to severe pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023988-17 | Sponsor Protocol Number: 260777 | Start Date*: 2014-04-04 | |||||||||||
Sponsor Name:BrepCo Biopharma Limited | |||||||||||||
Full Title: Management of Hypotension In the Preterm: A multi centre, randomised, controlled trial of hypotension management in the extremely low gestational age newborn | |||||||||||||
Medical condition: Low Blood Pressure | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Prematurely Ended) CZ (Prematurely Ended) BE (Prematurely Ended) GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016958-41 | Sponsor Protocol Number: FO002 | Start Date*: 2010-02-28 | ||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA` GRANDA (A.O. DI RILIEVO NAZIONALE) | ||||||||||||||||||
Full Title: Early LEvosimendan Vs usual care in Advanced chronic hearT failurE | ||||||||||||||||||
Medical condition: Advanced chronic heart failure | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.